An in-depth look to LIPIGON PHARMACEUTICALS AB operating, investing, and financing activities

LPGO free cash flow for Q2 24 is -8.74 M SEK. For 2023, LPGO free cash flow was -14.32 M SEK and operating cash flow was -14.32 M SEK.